Described herein are pharmaceutical packaging systems which avoid oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-delicate medicine, this kind of units which includes a syringe with the oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very reduced permeability to oxygen